About this trial

The goal of this study is to determine if estradiol and progesterone are involved in appetite regulation and energy balance. The study aims to complete a 13 day randomized controlled trial (RCT) where oral supplementation of estradiol only, progesterone only, a combination of each, or a placebo in young males will be provided. During the supplementation period, participants will complete two in-lab sessions where they will complete an acute bout of high-intensity interval training or a period of seated rest (completed on separate days by each participant) and have blood samples and perceptions of appetite measured taken over the course of the in-lab sessions. At the end of each session participants will consume an ad-libitum meal and participants will also track free-living energy intake and wear a thigh-worn accelerometer to measure energy expenditure for three days (day before, day of, and day after) each in-lab session.

Eligibility criteria

Qualifiers

ages 18-30 years

deemed healthy using Canadian Society for Exercise Physiology Get Active Questionnaire (CSEP-GAQ)

non-smoking

Disqualifiers

failure to meet inclusion criteria

contraindications to exercise as indicated by the (CSEP-GAQ)

hypersensitivity or allergy to estradiol, progesterone, cellulose, or capsule components

having been diagnosed with any metabolic disease (ie. diabetes, metabolic syndrome) or current diagnosis of overweight/obesity (BMI > 30.0)

Trial design

Treatments tested in this trial

  • Placebo Comparator
  • Estradiol Only
  • Progesterone Only
  • Estradiol and Progesterone Combination

Treatment groups

60 Participants
are divided into 4 treatment groups

Locations

1
Energy Metabolism Research LaboratoryN2L 3C5, WaterlooOntario, Canada

Sponsors and collaborators

Wilfrid Laurier University

Lead sponsor